Harris & Harris Group, an investor in transformative companies enabled by disruptive science, is to begin offering limited numbers of accredited investors the opportunity to co-invest with with teh firm in its portfolio companies through a newly-formed co-investment fund that will be managed by Harris & Harris Group.
“A consistent question we heard from our shareholders and other attendees at our Meet the Portfolio Day events and in other conversations was, 'Can I invest directly in your portfolio companies?' As our portfolio companies grow, we have rights to invest in future rounds of financing if we so choose,” says Douglas W Jamison, Chief Executive Officer of Harris & Harris Group. “These rights are often referred to as pre-emptive rights. We are excited to announce today that we will share, through our newly-formed co-investment fund, a portion of our rights with limited numbers of accredited investors, giving priority to those accredited investors who are also our shareholders.”
The opportunities to invest will be provided through H&H Co-Investment Partners,, a newly formed entity that will be managed by Harris & Harris Group. The firm expects to solicit interest in separate series established by H&H Co-Investment Partners to invest in individual portfolio companies, ahead of potential future rounds of financing. Accredited investors who have held Harris & Harris Group stock prior to the close of each financing, are expected to have priority in the allocation of these limited co-investment opportunities.
